| Schedule of Segment Reporting Information, by Segment [Table Text Block] |
| |
2018
|
|
2017
|
|
Net income (loss):
|
|
|
|
|
|
|
Cchek™ cancer detection platform
|
$
|
(5,920,457)
|
|
$
|
(5,014,164)
|
|
CAR-T therapeutics
|
|
(7,073,322)
|
|
|
(504,405)
|
|
Patent licensing
|
|
(1,249,305)
|
|
|
509,578
|
|
Total
|
$
|
(14,243,084)
|
|
$
|
(5,008,991)
|
| |
|
|
|
|
|
|
Operating costs and expenses
|
$
|
15,401,558
|
|
$
|
6,438,084
|
|
Less non-cash share based compensation
|
|
(8,895,614)
|
|
|
(1,676,772)
|
|
Operating costs and expenses excluding non-cash
share based compensation
|
$
|
6,505,944
|
|
$
|
4,761,312
|
| |
|
|
|
|
|
|
Operating costs and expenses excluding non-cash
share based compensation:
|
|
|
|
|
|
|
Cchek™ cancer detection platform
|
$
|
2,431,810
|
|
$
|
3,659,280
|
|
CAR-T therapeutics
|
|
2,120,614
|
|
|
342,064
|
|
Patent licensing
|
|
1,953,520
|
|
|
759,968
|
|
Total
|
$
|
6,505,944
|
|
$
|
4,761,312
|
| |
|
|
|
|
|
|
Total assets:
|
|
|
|
|
|
|
Cchek™ cancer detection platform
|
$
|
2,545,803
|
|
$
|
5,684,915
|
|
CAR-T therapeutics
|
|
2,157,359
|
|
|
521,326
|
|
Patent licensing
|
|
1,745,380
|
|
|
2,606,175
|
|
Total
|
$
|
6,448,542
|
|
$
|
8,812,416
|
|